Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands.

Tessa van der MaadenElizabeth N MutubukiSiméon de BruijnKa Yin LeungHans KnoopJaap SlootwegAnna D TulenAlbert WongAlbert Jan van HoekEelco FranzCees C van den Wijngaard

Published in: The Journal of infectious diseases (2022)

Three months after SARS-CoV-2 infection, almost half of cases report symptoms, which is higher than background prevalence and test-negative prevalence. Vaccination prior to infection was protective against loss of smell and taste in cases aged <65.

Keyphrases

sars cov
risk factors
respiratory syndrome coronavirus
sleep quality
depressive symptoms